72 results
Page 2 of 4
424B5
qx8uc
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
mygrxztvq 3ivzirgf8
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
8qo9gj3na 23fonj6
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
x0e4lop55jt evi4q
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
yyjta4ni
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-10.1
b33 8s9zdr
26 Jun 20
Departure of Directors or Certain Officers
4:06pm
425
jay71mzvxah3ggsbjj
24 Jun 20
Business combination disclosure
5:11pm
8-K
warijft
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-2.1
ed7gf
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
cruct9r4
24 Jun 20
Business combination disclosure
4:03pm
425
8k2d3ulo
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
q6lh3g 4nk
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
tkc1hrvhjp
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm